0 оценок0% нашли этот документ полезным (0 голосов)
22 просмотров2 страницы
More than 900 scientists are expected in Marseille, France, on 21-23 May 2014 to find answers regarding implementation of anti-HIV therapy and anti-HCV therapy and the spread of new viral threats.
Оригинальное название
Experts in Virology Meet in Marseille this Month to Find Curative Therapies against HIV and Tackle other Viral Threats
More than 900 scientists are expected in Marseille, France, on 21-23 May 2014 to find answers regarding implementation of anti-HIV therapy and anti-HCV therapy and the spread of new viral threats.
More than 900 scientists are expected in Marseille, France, on 21-23 May 2014 to find answers regarding implementation of anti-HIV therapy and anti-HCV therapy and the spread of new viral threats.
Experts in Virology Meet in Marseille this Month to Find Curative Therapies agai
nst HIV and Tackle other Viral Threats
More than 900 scientists are expected in Marseille, France, on 21-23 May 2014 to find answers regarding implementation of anti-HIV therapy and anti-HCV therapy and the spread of new viral threats. Toulon, Var, France., May 05, 2014 -- The International Symposium on HIV and Eme rging Infectious Diseases (ISHEID) will take place at the Parc Chanot Congress C enter in Marseille, France, on May 21-23, 2014. More than 900 international expe rts are expected to make progress on HIV cure, worldwide implementation of anti- HIV andanti- hepatitis C (HCV) therapies, and address the issue of other emergin g viral diseases. First, HIV, the virus that causes AIDS, infects 34 million individuals worldwide with 29 millions in sub-Saharan Africa where access to antiretroviral therapy i s limited. The World AIDS Organization (WHO) has defined the main goal regarding this pandemic to be Zero new infection, zero discrimination, zero death but WHO is st ill far from reaching it. The ISHEID will tackle the issues of HIV prevention, HIV vaccine, HIV treatment acc ess, with the main international experts of the field said Alain Lafeuillade, MD, P resident of the Symposium. Then, HIV cannot yet be eradicated from an infected host but there is hope to fi nd a functional cure in a next future. This kind of cure is a situation where HIV is n ot eradicated but its replication controlled without the need to maintain antire troviral therapy. Update on these approaches for a cure along with the developme nt of an anti-HIV therapeutic vaccine will be given at the ISHEID. Regarding HCV, this virus infects more than 300 million individuals worldwide an d leads to liver cirrhosis and cancer. In 2014, for the first time, are coming t o the market new anti-HCV drugs able to definitively cure every patient infected by HCV. But the cost of one single treatment averages 100,000 euros, meaning th at access is already limited for economical reasons. Medical doctors, patients a nd activists cannot accept that politicians and pharmaceutical companies give ac cess to these treatments only to HCV-infected patients from rich countries. These economic considerations are also in the front line regarding viral researc h against new viral threats that challenge the world. For 2 years the deadly Mid dle East Respiratory Syndrome Coronovirus is spreading outside its initial regio n of development and millions of pilgrims expected to Mecca next July and at the fall have the potential to accelerate MERS-co spread. Hepatitis E is already widely distributed and there is no therapy against it. The nightmare of virologists is the existence of deadly flu strains like H5N1 an d H7N9 that have the potential to rapidly spread with worldwide air travel, as E bola virus can too. The prediction is that there is a risk that these viruses be come the main challenge within a few years. The ISHEID will also tackle these th reats. The ISHEID is organized under the auspices of the French Agency for AIDS and Vir al Hepatitis Research (ANRS). Contact: Alain Lafeuillade Department of Infectious Diseases, General Hospital, ISHEID Toulon, france +3-349-414-5084 lafeuillade@orange.fr http://www.isheid.com